MARKET INTRODUCTION
Acute pancreatitis is an inflammation of pancreas which is mainly caused due to alcoholism and gallstones. Sudden pain in upper abdominal part, vomiting, nausea, loss of appetite, and deep breathing are some of the symptoms showed by acute pancreatitis.
MARKET DYNAMICS
The acute pancreatitis market is expected to witness considerable growth due to significant prevalence of acute pancreatitis. Moreover, significant research and development activities for the disease are also estimated to offer lucrative environment for the market growth. However, lack of infrastructure and stringent government regulations are expected to hamper the growth of the global acute pancreatitis market.
MARKET SCOPE
The "Acute Pancreatitis Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Acute Pancreatitis Market with detailed market segmentation by treatment and end user. The Acute Pancreatitis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Acute Pancreatitis Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The acute pancreatitis market is segmented on the basis of treatment. Based on treatment, the market is segmented as intravenous fluid, analgesics, nutritional support, endoscopic retrograde cholangiopancreatography (ERCP), and others. Based on end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Acute Pancreatitis Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Acute Pancreatitis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Acute Pancreatitis Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Acute Pancreatitis Market in these regions.
MARKET PLAYERS
The report covers key developments in the Acute Pancreatitis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Acute Pancreatitis Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Acute Pancreatitis Market.
The report also includes the profiles of key players in Acute Pancreatitis Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- CalciMedica
- SCM Lifescience
- Samsung Bioepis
- GNT Pharma Co.
- Baxter International Inc.
- B. Braun Melsungen AG
- General Electric Company
- Medtronic
- Boston Scientific Corporation
- Fresenius Kabi USA
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Acute Pancreatitis Market - By Treatment
1.3.2 Acute Pancreatitis Market - By End User
1.3.3 Acute Pancreatitis Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ACUTE PANCREATITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ACUTE PANCREATITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ACUTE PANCREATITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. ACUTE PANCREATITIS - GLOBAL MARKET OVERVIEW
6.2. ACUTE PANCREATITIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ACUTE PANCREATITIS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. INTRAVENOUS FLUID
7.3.1. Overview
7.3.2. Intravenous Fluid Market Forecast and Analysis
7.4. ANALGESICS
7.4.1. Overview
7.4.2. Analgesics Market Forecast and Analysis
7.5. NUTRITIONAL SUPPORT
7.5.1. Overview
7.5.2. Nutritional Support Market Forecast and Analysis
7.6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP)
7.6.1. Overview
7.6.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ACUTE PANCREATITIS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ACUTE PANCREATITIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Acute Pancreatitis Market Overview
9.1.2 North America Acute Pancreatitis Market Forecasts and Analysis
9.1.3 North America Acute Pancreatitis Market Forecasts and Analysis - By Treatment
9.1.4 North America Acute Pancreatitis Market Forecasts and Analysis - By End User
9.1.5 North America Acute Pancreatitis Market Forecasts and Analysis - By Countries
9.1.5.1 United States Acute Pancreatitis Market
9.1.5.1.1 United States Acute Pancreatitis Market by Treatment
9.1.5.1.2 United States Acute Pancreatitis Market by End User
9.1.5.2 Canada Acute Pancreatitis Market
9.1.5.2.1 Canada Acute Pancreatitis Market by Treatment
9.1.5.2.2 Canada Acute Pancreatitis Market by End User
9.1.5.3 Mexico Acute Pancreatitis Market
9.1.5.3.1 Mexico Acute Pancreatitis Market by Treatment
9.1.5.3.2 Mexico Acute Pancreatitis Market by End User
9.2. EUROPE
9.2.1 Europe Acute Pancreatitis Market Overview
9.2.2 Europe Acute Pancreatitis Market Forecasts and Analysis
9.2.3 Europe Acute Pancreatitis Market Forecasts and Analysis - By Treatment
9.2.4 Europe Acute Pancreatitis Market Forecasts and Analysis - By End User
9.2.5 Europe Acute Pancreatitis Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Acute Pancreatitis Market
9.2.5.1.1 Germany Acute Pancreatitis Market by Treatment
9.2.5.1.2 Germany Acute Pancreatitis Market by End User
9.2.5.2 France Acute Pancreatitis Market
9.2.5.2.1 France Acute Pancreatitis Market by Treatment
9.2.5.2.2 France Acute Pancreatitis Market by End User
9.2.5.3 Italy Acute Pancreatitis Market
9.2.5.3.1 Italy Acute Pancreatitis Market by Treatment
9.2.5.3.2 Italy Acute Pancreatitis Market by End User
9.2.5.4 Spain Acute Pancreatitis Market
9.2.5.4.1 Spain Acute Pancreatitis Market by Treatment
9.2.5.4.2 Spain Acute Pancreatitis Market by End User
9.2.5.5 United Kingdom Acute Pancreatitis Market
9.2.5.5.1 United Kingdom Acute Pancreatitis Market by Treatment
9.2.5.5.2 United Kingdom Acute Pancreatitis Market by End User
9.2.5.6 Rest of Europe Acute Pancreatitis Market
9.2.5.6.1 Rest of Europe Acute Pancreatitis Market by Treatment
9.2.5.6.2 Rest of Europe Acute Pancreatitis Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Acute Pancreatitis Market Overview
9.3.2 Asia-Pacific Acute Pancreatitis Market Forecasts and Analysis
9.3.3 Asia-Pacific Acute Pancreatitis Market Forecasts and Analysis - By Treatment
9.3.4 Asia-Pacific Acute Pancreatitis Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Acute Pancreatitis Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Acute Pancreatitis Market
9.3.5.1.1 Australia Acute Pancreatitis Market by Treatment
9.3.5.1.2 Australia Acute Pancreatitis Market by End User
9.3.5.2 China Acute Pancreatitis Market
9.3.5.2.1 China Acute Pancreatitis Market by Treatment
9.3.5.2.2 China Acute Pancreatitis Market by End User
9.3.5.3 India Acute Pancreatitis Market
9.3.5.3.1 India Acute Pancreatitis Market by Treatment
9.3.5.3.2 India Acute Pancreatitis Market by End User
9.3.5.4 Japan Acute Pancreatitis Market
9.3.5.4.1 Japan Acute Pancreatitis Market by Treatment
9.3.5.4.2 Japan Acute Pancreatitis Market by End User
9.3.5.5 South Korea Acute Pancreatitis Market
9.3.5.5.1 South Korea Acute Pancreatitis Market by Treatment
9.3.5.5.2 South Korea Acute Pancreatitis Market by End User
9.3.5.6 Rest of Asia-Pacific Acute Pancreatitis Market
9.3.5.6.1 Rest of Asia-Pacific Acute Pancreatitis Market by Treatment
9.3.5.6.2 Rest of Asia-Pacific Acute Pancreatitis Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Acute Pancreatitis Market Overview
9.4.2 Middle East and Africa Acute Pancreatitis Market Forecasts and Analysis
9.4.3 Middle East and Africa Acute Pancreatitis Market Forecasts and Analysis - By Treatment
9.4.4 Middle East and Africa Acute Pancreatitis Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Acute Pancreatitis Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Acute Pancreatitis Market
9.4.5.1.1 South Africa Acute Pancreatitis Market by Treatment
9.4.5.1.2 South Africa Acute Pancreatitis Market by End User
9.4.5.2 Saudi Arabia Acute Pancreatitis Market
9.4.5.2.1 Saudi Arabia Acute Pancreatitis Market by Treatment
9.4.5.2.2 Saudi Arabia Acute Pancreatitis Market by End User
9.4.5.3 U.A.E Acute Pancreatitis Market
9.4.5.3.1 U.A.E Acute Pancreatitis Market by Treatment
9.4.5.3.2 U.A.E Acute Pancreatitis Market by End User
9.4.5.4 Rest of Middle East and Africa Acute Pancreatitis Market
9.4.5.4.1 Rest of Middle East and Africa Acute Pancreatitis Market by Treatment
9.4.5.4.2 Rest of Middle East and Africa Acute Pancreatitis Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Acute Pancreatitis Market Overview
9.5.2 South and Central America Acute Pancreatitis Market Forecasts and Analysis
9.5.3 South and Central America Acute Pancreatitis Market Forecasts and Analysis - By Treatment
9.5.4 South and Central America Acute Pancreatitis Market Forecasts and Analysis - By End User
9.5.5 South and Central America Acute Pancreatitis Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Acute Pancreatitis Market
9.5.5.1.1 Brazil Acute Pancreatitis Market by Treatment
9.5.5.1.2 Brazil Acute Pancreatitis Market by End User
9.5.5.2 Argentina Acute Pancreatitis Market
9.5.5.2.1 Argentina Acute Pancreatitis Market by Treatment
9.5.5.2.2 Argentina Acute Pancreatitis Market by End User
9.5.5.3 Rest of South and Central America Acute Pancreatitis Market
9.5.5.3.1 Rest of South and Central America Acute Pancreatitis Market by Treatment
9.5.5.3.2 Rest of South and Central America Acute Pancreatitis Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ACUTE PANCREATITIS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ACUTE PANCREATITIS MARKET, KEY COMPANY PROFILES
12.1. CALCIMEDICA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SCM LIFESCIENCE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SAMSUNG BIOEPIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GNT PHARMA CO.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAXTER INTERNATIONAL INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. B. BRAUN MELSUNGEN AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENERAL ELECTRIC COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEDTRONIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BOSTON SCIENTIFIC CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FRESENIUS KABI USA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. CalciMedica
2. SCM Lifescience
3. Samsung Bioepis
4. GNT Pharma Co.
5. Baxter International Inc.
6. B. Braun Melsungen AG
7. General Electric Company
8. Medtronic
9. Boston Scientific Corporation
10. Fresenius Kabi USA